Supporting scale-up of COVID-19 RT-PCR testing processes with discrete event simulation
PublisherPublic Library of Science
MetadataShow full item record
AbstractTesting is critical to mitigating the COVID-19 pandemic, but testing capacity has fallen short of the need in the United States and elsewhere, and long wait times have impeded rapid isolation of cases. Operational challenges such as supply problems and personnel shortages have led to these bottlenecks and inhibited the scale-up of testing to needed levels. This paper uses operational simulations to facilitate rapid scale-up of testing capacity during this public health emergency. Specifically, discrete event simulation models were developed to represent the RT-PCR testing process in a large University of Maryland testing center, which retrofitted high-throughput molecular testing capacity to meet pandemic demands in a partnership with the State of Maryland. The simulation models support analyses that identify process steps which create bottlenecks, and evaluate "what-if" scenarios for process changes that could expand testing capacity. This enables virtual experimentation to understand the trade-offs associated with different interventions that increase testing capacity, allowing the identification of solutions that have high leverage at a feasible and acceptable cost. For example, using a virucidal collection medium which enables safe discarding of swabs at the point of collection removed a time-consuming "deswabbing" step (a primary bottleneck in this laboratory) and nearly doubled the testing capacity. The models are also used to estimate the impact of demand variability on laboratory performance and the minimum equipment and personnel required to meet various target capacities, assisting in scale-up for any laboratories following the same process steps. In sum, the results demonstrate that by using simulation modeling of the operations of SARS-CoV-2 RT-PCR testing, preparedness planners are able to identify high-leverage process changes to increase testing capacity.
Keyworddiscrete event simulation
laboratory operational processes
SARS-CoV-2 RT-PCR testing
COVID-19 Nucleic Acid Testing--methods
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16287
- Development and implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities.
- Authors: Ceci A, Muñoz-Ballester C, Tegge AN, Brown KL, Umans RA, Michel FM, Patel D, Tewari B, Martin J, Alcoreza O, Maynard T, Martinez-Martinez D, Bordwine P, Bissell N, Friedlander MJ, Sontheimer H, Finkielstein CV
- Issue date: 2021 Jul 20
- Development, deployment and in-field demonstration of mobile coronavirus SARS-CoV-2 Nucleic acid amplification test.
- Authors: Paton TF, Marr I, O'Keefe Z, Inglis TJJ
- Issue date: 2021 Apr
- Expanding molecular diagnostic capacity for COVID-19 in Ethiopia: operational implications, challenges and lessons learnt.
- Authors: Kebede A, Lanyero B, Beyene B, Mandalia ML, Melese D, Girmachew F, Mekonnen A, Ayana G, Yemanebirhan N, Hailu G, Asrat H, Nurahmed N, Gashu A, Eshetu K, Assefa Z, Abayneh A, Musa E, Abate E
- Issue date: 2021
- Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification.
- Authors: Lalli MA, Langmade JS, Chen X, Fronick CC, Sawyer CS, Burcea LC, Wilkinson MN, Fulton RS, Heinz M, Buchser WJ, Head RD, Mitra RD, Milbrandt J
- Issue date: 2021 Jan 30
- Impact of Pool Testing in Detection of Asymptomatic Patients with COVID-19.
- Authors: Smalley DL, Cisarik PM, Grantham J, Cloud W, Neil RB, DePriest P
- Issue date: 2021 Jan 4